At a recent science and technology innovation conference in Hubei Province, Yichang HEC Biochemical Pharmaceutical CoLtd, in collaboration with domestic academic institutions, was awarded the second prize of the Hubei Provincial Science and Technology Advancement Award for its innovation in green biological manufacturing of bulk antibiotics.

　　As a pharmaceutical enterprise specializing in erythromycin, lincomycin and enzyme-based products, HEC operates the world’s largest, highest-quality and most technologically advanced production center for macrolide active pharmaceutical ingredients, holding over 65% of the global market share. In 2024, HEC was recognized as a “Moose” enterprise, a designation for high-growth industrial leaders. In 2025, its revenue reached 3.8 billion yuan. With more than 40 core patents, the company has been shaping industry standards and reinforcing its global leadership through continuous technological advancement.(Sanxia Daily: Reporters/Fang Yonghua and Sun Yumin, Correspondent/Xu Lei)